Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 1.000 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.534 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.533 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.531 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.520 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.514 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.513 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.510 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.510 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.506 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.502 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.501 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.491 | |
| 4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.487 | |
| 2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
| 2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.475 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
| 2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
| 4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
| 4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.467 | |
| 2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.465 | |
| 4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
| 1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.459 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.459 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.458 | |
| 1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.457 | |
| 3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.455 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.455 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.455 | |
| 1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.454 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.453 | |
| 3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.450 | |
| 1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.450 | |
| 4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
| 4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.449 | |
| 3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
| 1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.447 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.447 | |
| 4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3gu5 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.444 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.443 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.442 | |
| 4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3qtq | X35 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.441 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 |